Volver a Agenda
Session 25: Beyond Approval - Post-Approval Changes
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- This section will drill down into the realm of post-approval changes such as PAS's, CBE's, and ARs
- SUPAC documents will be discussed which are integral in the post approval world
¿Tiene una cuenta?